Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.
作者信息
Healy D L, Fraser H M, Lawson S L
出版信息
Br Med J (Clin Res Ed). 1984 Nov 10;289(6454):1267-8. doi: 10.1136/bmj.289.6454.1267.
Abstract
摘要
相似文献
1
Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.
Br Med J (Clin Res Ed). 1984 Nov 10;289(6454):1267-8. doi: 10.1136/bmj.289.6454.1267.
2
Shrinkage of uterine fibroids by preoperative LHRH analogue injection.术前注射促性腺激素释放激素类似物使子宫肌瘤缩小。
Ulster Med J. 1992 Apr;61(1):51-5.
3
[Shrinkage of uterine leiomyomas after intranasal administration of a LHRH agonist].经鼻给予促黄体生成素释放激素激动剂后子宫平滑肌瘤的缩小
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Mar;41(3):365-8.
4
Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women.
Fertil Steril. 1990 Dec;54(6):1032-8. doi: 10.1016/s0015-0282(16)54001-1.
5
Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.迈向非手术去除子宫肌瘤：在黄体期开始皮下输注促黄体生成素释放激素激动剂。
J Clin Endocrinol Metab. 1986 Sep;63(3):619-25. doi: 10.1210/jcem-63-3-619.
6
Uterine leiomyoma: treatment with LHRH agonist.
Prog Clin Biol Res. 1986;225:297-311.
7
Pelvic pain complicating LHRH analogue treatment of fibroids.
Aust N Z J Obstet Gynaecol. 1991 Nov;31(4):383-4. doi: 10.1111/j.1479-828x.1991.tb02831.x.
8
Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
Prog Clin Biol Res. 1986;225:313-20.
9
Clinical application of a gonadotropin releasing hormone analog (buserelin) in the treatment of uterine leiomyomas.促性腺激素释放激素类似物（布舍瑞林）在子宫肌瘤治疗中的临床应用。
Int J Gynaecol Obstet. 1992 May;38(1):52-3. doi: 10.1016/0020-7292(92)90732-x.
10
Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin.
Br J Obstet Gynaecol. 1989 Feb;96(2):200-6. doi: 10.1111/j.1471-0528.1989.tb01663.x.
引用本文的文献
1
GnRH agonists and antagonists. Current clinical status.促性腺激素释放激素激动剂和拮抗剂。当前临床状况。
Drugs. 1988 Jan;35(1):63-82. doi: 10.2165/00003495-198835010-00004.
2
Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.促黄体生成素释放激素激动剂类似物所致性腺功能减退：对绝经前女性骨密度的影响
Br Med J (Clin Res Ed). 1987 Jun 13;294(6586):1523-4. doi: 10.1136/bmj.294.6586.1523.
3
Failure to preserve fertility in patients with Hodgkin's disease.霍奇金病患者生育力保存失败。
Cancer Chemother Pharmacol. 1987;19(2):159-62. doi: 10.1007/BF00254570.
4
Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.促黄体生成激素释放激素及其类似物：生物学特性与临床应用综述
J Endocrinol Invest. 1988 Jul-Aug;11(7):535-57. doi: 10.1007/BF03350179.
本文引用的文献
1
Leiomyomas: steroid receptor content. Variation within normal menstrual cycles.平滑肌瘤：类固醇受体含量。正常月经周期内的变化。
Am J Obstet Gynecol. 1982 May 1;143(1):6-11. doi: 10.1016/0002-9378(82)90676-7.
2
New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent.促黄体生成激素释放激素作为一种避孕和治疗药物的新前景。
Br Med J (Clin Res Ed). 1982 Oct 9;285(6347):990-1. doi: 10.1136/bmj.285.6347.990.
3
Management of pelvic endometriosis by means of intraabdominal carbon dioxide laser.
Fertil Steril. 1984 Jan;41(1):14-9.
4
A miniature infuser for the pulsatile administration of LHRH.一种用于脉冲式注射促性腺激素释放激素（LHRH）的微型注射器。
J Biomed Eng. 1984 Apr;6(2):129-33. doi: 10.1016/0141-5425(84)90055-4.
5
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
Am J Obstet Gynecol. 1983 Nov 15;147(6):726-7. doi: 10.1016/0002-9378(83)90463-5.
Zotero 插件